|
(b)(4).Date sent to the fda: 03/20/2018.(b)(4).Additional information was requested and the following was obtained: what tissue was the stratafix spiral suture used on? subcuticular what was the condition of the tissue where suture was used (normal, diseased, weakened)? patient had a higher bmi, surgeon noted after surgery the knee was swelled considerably.Was the stratafix spiral placed while the knee was in flexion? yes.Was there any patient predisposing event (cough, fall, etc) prior to wound opening? unknown.What is the surgeon opinion as to relationship of the stratafix suture and the patient dehiscence? patient had a higher bmi and significant swelling after surgery which may have contributed.What was the appearance of the stratafix spiral when the wound opened? unknown was a second procedure performed to close the wound? dermabond advanced was applied.Was the suture found broken, can you identify where (termination, middle, end)? unknown.Was the suture intact and pulled through the tissue? unknown.Can you identify the lot number of the sxmp1b110 stratafix spiral suture? no.What is the current condition of the patient? surgeon reported patient is doing fine.
|